RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/27430526http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/27430526http://www.w3.org/2000/01/rdf-schema#comment"Immune checkpoint inhibitors result in impressive clinical responses and are expanding to treat a wide variety of tumors. One common problem is low responses from current clinical trials that only benefit a fraction of patients. One key promising direction is combination therapy to increase clinical benefit. CD137, a well-defined antitumor target, can cause strong co-stimulating activity and break immune tolerance. In this study, the role of CD137-CRDI (cysteine rich domain I) in the binding of CD137-CD137L was further investigated based on our previous work. The results revealed that CRDI-mediated limited CD137 assembly without relying on CD137L. Furthermore, CRDI was not involved in direct contact with CD137L in either mice or humans. Isolated mouse CRDII and human CRDII+CRDIII were proven to be the minimum unit for interface with their respective ligands. Fine-tuning of this signaling may improve CD137-targeting strategy."xsd:string
http://purl.uniprot.org/citations/27430526http://purl.org/dc/terms/identifier"doi:10.1038/icb.2016.64"xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/author"Jia H."xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/author"Zhang H."xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/author"Wang X."xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/author"Zhao Y."xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/author"Yan Z."xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/author"Yi L."xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/name"Immunol Cell Biol"xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/pages"24-32"xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/title"CD137-CRDI is not necessary in the role of contacting its natural ligand."xsd:string
http://purl.uniprot.org/citations/27430526http://purl.uniprot.org/core/volume"95"xsd:string
http://purl.uniprot.org/citations/27430526http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/27430526
http://purl.uniprot.org/citations/27430526http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/27430526
http://purl.uniprot.org/uniprot/#_P20334-mappedCitation-27430526http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27430526
http://purl.uniprot.org/uniprot/#_Q07011-mappedCitation-27430526http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27430526
http://purl.uniprot.org/uniprot/#_Q3U3R1-mappedCitation-27430526http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27430526
http://purl.uniprot.org/uniprot/#_Q6ZUN9-mappedCitation-27430526http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27430526
http://purl.uniprot.org/uniprot/#_Q8R037-mappedCitation-27430526http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27430526
http://purl.uniprot.org/uniprot/Q8R037http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/27430526
http://purl.uniprot.org/uniprot/P20334http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/27430526
http://purl.uniprot.org/uniprot/Q3U3R1http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/27430526
http://purl.uniprot.org/uniprot/Q07011http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/27430526